[1]冯曲波,颜 婷,伍国林.2014年~2016年我院质子泵抑制剂应用分析[J].医学信息,2018,31(08):116-118.[doi:10.3969/j.issn.1006-1959.2018.08.039]
 FENG Qu-bo,YAN Ting,WU Guo-lin.Application of Proton Pump Inhibitors in our Hospital from 2014 to 2016[J].Journal of Medical Information,2018,31(08):116-118.[doi:10.3969/j.issn.1006-1959.2018.08.039]
点击复制

2014年~2016年我院质子泵抑制剂应用分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
116-118
栏目:
调查分析
出版日期:
2018-04-15

文章信息/Info

Title:
Application of Proton Pump Inhibitors in our Hospital from 2014 to 2016
文章编号:
1006-1959(2018)08-0116-03
作者:
冯曲波1颜 婷2伍国林3
1.四川省林业中心医院药剂科,四川 成都 610081; 2.四川省医学科学院/四川省人民医院/电子科技大学附属医院药剂科, 四川 成都 610072; 3.四川省妇幼保健院药剂科, 四川 成都 610045
Author(s):
FENG Qu-bo1YAN Ting2WU Guo-lin3
1.Department of Pharmacy,Sichuan Forestry Center Hospital,Chengdu 610081,Sichuan,China; 2. Department of pharmacy,Affiliated Hospital of Sichuan Academy of Medical Sciences/Sichuan Provincial People's Hospital/Sichuan University of Electronic Science and
关键词:
质子泵抑制剂使用频度日均费用用药分析
Keywords:
Key words:Proton pump inhibitorFrequency of useDaily average costDrug analysis
分类号:
R95
DOI:
10.3969/j.issn.1006-1959.2018.08.039
文献标志码:
A
摘要:
目的 分析我院2014年~2016年质子泵抑制剂的使用情况。方法 利用HIS系统,对我院2014年~2016年PPIs的用药金额、使用频度和日均费用等进行统计分析。结果 2014年~2016年我院质子泵抑制剂总的用药金额程逐年增长趋势,2016年与2015年相比降低6.91万,3年间我院使用的PPIs不同生产厂家及品规共计7个,其中注射剂3个、口服制剂4个;金额排名前三的是注射用泮托拉唑、奥美拉唑和兰索拉唑肠溶片;3年间兰索拉唑肠溶片、注射用泮托拉唑DDDs分别位居1、2位,使用频率高;注射用泮托拉唑、奥美拉唑DDC较高,排序比均小于1表明2种药品价格水平较高。结论 注射用泮托拉唑、奥美拉唑用药金额较大等不合理现象。
Abstract:
Abstract:Objective To analyze the use of proton pump inhibitors in our hospital from 2014 to 2016.Methods Using HIS system, the sum of money,frequency and daily average cost of PPIs used in our hospital from 2014 to 2016 were analyzed statistically.Results From 2014 to 2016,the total dosage of proton pump inhibitors in our hospital increased year by year.In 2016,the number of PPIs used in our hospital decreased by 69,100 compared with 2015.In 3 years,there were 7 different PPIs manufacturers and regulations used by our hospital, including 3 injections and 4 oral preparations;The top three in the amount was pantoprazole for injection,omeprazole,and lansoprazole enteric-coated tablets;for three years,lansoprazole enteric-coated tablets and pantoprazole DDDs for injection were ranked in the first and second positions,respectively.The use frequency is high;Pantoprazole and omeprazole DDC were higher for injection, and the ordering ratio was less than 1,indicating that the price level of the 2 drugs was higher.Conclusion The amount of pantoprazole and omeprazole for injection is unreasonable.

参考文献/References:

[1]陈新歉,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2013.
[2]王琨,段丽萍.长期使用质子泵抑制剂可能导致的副作用分析[J].胃肠病学和肝病学杂志,2010,19(8):766.
[3]朱爱国,王建,张桂芳.我院2011-2013年质子泵抑制剂应用分析[J].中国药房,2015,26(14):1914.
[4]黄兴富,周慧,郭建伟,等.1239例注射用质子泵抑制剂专项点评[J].China Licensed Pharmacist,2016,13(8):5.
[5]黄瑾,刘正跃,田泾.长期大剂量使用质子泵抑制剂的严重不良反应和药学监护[J].中国医院药学杂志,2012,32(20):1648-1651.
[6]张增珠,李刚,陈集志,等.质子泵抑制剂长期用药的临床风险[J].中国药物警戒,2013,10(11):664.
[7]黄艳兰,应激性溃疡危险因素预防循证指南[J].中国煤炭工业医学杂志,2009,12(11):1826.
[8]刘宇宏,王世鑫.近年来质子泵抑制剂的研究进展[J].中国新药杂志,2001,10(3):161.
[9]贺金凯,贺翠婷,刘鹰,等.质子泵抑制剂泮托拉唑的研究进展[J],中国药房,2016,27(26):3732.
[10]雷永芳,刘东.武汉地区34家医院质子泵抑制剂应用分析[J],解放军药学学报,2016,32(2):191.

相似文献/References:

[1]毕月玲,潘丽华,闫永悦.2017年第一、二季度我院口服质子泵抑制剂 应用情况分析[J].医学信息,2018,31(10):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
 BI Yue-ling,PAN Li-hua,YAN Yong-yue.Application of Oral Proton Pump Inhibitors in our Hospital in the First,Second Quarter of 2017[J].Journal of Medical Information,2018,31(08):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
[2]何志钧,梁运啸,梁列新.质子泵抑制剂治疗上消化道出血对痛风复发的影响[J].医学信息,2019,32(01):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
 HE Zhi-jun,LIANG Yun-xiao,LIANG Lie-xin.Effect of Proton Pump Inhibitor on Upper Gastrointestinal Hemorrhage on Recurrence of Gout[J].Journal of Medical Information,2019,32(08):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
[3]高 彦.强化药学干预对喹诺酮类药物临床应用合理性的影响[J].医学信息,2019,32(19):149.[doi:10.3969/j.issn.1006-1959.2019.19.048]
 GAO Yan.Effect of Intensive Pharmaceutical Intervention on the Rationality of Clinical Application of Quinolones[J].Journal of Medical Information,2019,32(08):149.[doi:10.3969/j.issn.1006-1959.2019.19.048]
[4]桑腮芳.胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果[J].医学信息,2024,37(02):149.[doi:10.3969/j.issn.1006-1959.2024.02.031]
 SANG Sai-fang.Clinical Effect of Gastric Mucosal Protective Agent Combined with Hydrogen Pump Inhibitors in the Treatment of Peptic Ulcer Bleeding[J].Journal of Medical Information,2024,37(08):149.[doi:10.3969/j.issn.1006-1959.2024.02.031]
[5]张金富,周细妹.质子泵抑制剂联合铝镁加混悬液治疗胃内镜黏膜溃疡的临床价值[J].医学信息,2024,37(07):127.[doi:10.3969/j.issn.1006-1959.2024.07.025]
 ZHANG Jin-fu,ZHOU Xi-mei.Clinical Value of Proton Pump Inhibitor Combined with Aluminum Magnesium Suspension in the Treatment of Gastric Endoscopic Mucosal Ulcer[J].Journal of Medical Information,2024,37(08):127.[doi:10.3969/j.issn.1006-1959.2024.07.025]

更新日期/Last Update: 2018-04-15